Accuracy of continuous nocturnal glucose monitoring after 48 and 72 hours in type 2 diabetes patients on combined oral and insulin therapy

Diabetes and Metabolism

Volumn 30, Issue 6, 2004, Pages 517-521

  Nyback Nakell A ^a   Von Heijne, M ^a   Adamson, U ^a   Lins, P E ^a   Landstedt Hallin, L ^a  

^a DANDERYD HOSPITAL   (Sweden)

Author keywords

CGMS; Continuous glucose monitoring; Nocturnal

Indexed keywords

INSULIN LISPRO; ISOPHANE INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; REPAGLINIDE;

ADULT; ARTICLE; CALIBRATION; CLINICAL ARTICLE; CONTINUOUS NOCTURNAL GLUCOSE MONITORING; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; NIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; REGISTRATION; SENSOR; STATISTICAL ANALYSIS; VENOUS BLOOD;

EID: 11244349112     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70149-0     Document Type: Article

References (18)

1. Gross TM, Mastrototaro JJ. Efficacy and reliability of continuous glucose monitoring systems. Diabetes Technol Ther, 2000, 2, 19-26.
2. Gross TM, Bode BW, Einhorn D, et al. Performance evaluation of the Minimed continuous glucose monitoring system during patient home use. Diabetes Technol Ther, 2000, 2, 49-56.
3. Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care, 2001, 24, 2030-4.
4. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of convential methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care, 2001, 24, 1858-62.
5. Guerci B, Floriot M, Bohme P, et al. Clinical Performance of CMGS in Type 1 Diabetic Patients Treated by Continuous Subcutaneous Insulin Infusion Using Insulin Analogs. Diabetes Care, 2003, 26, 582-9.
6. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics, 2003, 111, 933-8.
7. Chico A, Vidal-Rios P, Subira M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognised hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care, 2003, 26, 1153-7.
8. McGowan K, Thomas W, Moran A. Spurious reporting of nocturnal hypoglycaemia by CGMS in patients with tightly controlled type I diabetes. Diabetes Care, 2002, 25, 1499-503.
9. Metzger M, Leibovitz G, Wainstein J, Celaser B, Raz I. Reproducibility of glucose measurements using the glucose sensor. Diabetes Care, 2002, 25, 1185-91.
10. Mastrototaro JJ, Gross TM. Reproducibility of the Continuous Glucose Monitoring System matches previous reports and the intended use of the product. Diabetes Care, 2003, 26, 256.
11. Weinzimer SA, DeLucia MC, Boland EA, Steffen A, Tamborlane WV. Analysis of continuous glucose monitoring data from non-diabetic and diabetic children: a tale of two algorithms. Diabetes Technol Ther, 2003, 5, 375-80.
12. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet, 1986, 8, 307-10.
13. Clark WL, Cox D, Gonder Frederic LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for self monitoring of blood glucose. Diabetes Care, 1987, 10, 622-8.
14. Djakoure'-Platonoff C, Radermercker R, Reach G, Slama G, Selam J. Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions. Diabetes Metab, 2003, 29, 159-62.
15. Sachedina N, Pickup JC. Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in type 1 diabetic subjects. Diabetic Medicine, 2003, 20, 1012-5.
16. Gross TM, Ter Veer A. Continuous glucose monitoring in previously unstudied population subgroups. Diabetes Technol Ther, 2000, suppl.1, 27-34.
17. Gerritsen M. Problems associated with subcutaneously implanted glucose sensors. Diabetes Care, 2000, 23, 143-4.
18. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract, 1999, 46, 183-90.